Brightspring Health Services, Inc. (BTSG) Stock Price & Analysis

Brightspring Health Services, Inc. (BTSG) rose 4.40% to USD 72.91 as of July 25, 2026 at 03:02 UTC, according to Nexqual real-time market data.

BTSG last closed at USD 69.84; the session ranged USD 70.96–73.4 on volume of 2,471,663 shares. Market capitalization is $14.31B, with a 52-week range of USD 19.01–73.4 (NMS). Source: Nexqual, July 25, 2026 at 03:02 UTC.

Key Statistics (as of July 25, 2026 at 03:02 UTC)

Technical Analysis (BTSG)

Nexqual's technical model rates BTSG "BUY" based on 5 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 03:02 UTC.

Analyst Ratings (BTSG)

Wall Street analysts rate BTSG "Strong Buy" based on 17 analysts, with a mean price target of USD 76.29 (range USD 49–90), per Nexqual as of July 25, 2026 at 03:02 UTC.

Earnings (BTSG)

Recent Earnings History

Source: Nexqual, July 25, 2026 at 03:02 UTC.

Financials & Fundamentals (BTSG)

Source: Nexqual, July 25, 2026 at 03:02 UTC.

Financial Health Score (BTSG)

Nexqual rates Brightspring Health Services, Inc.'s overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 03:02 UTC.

Ownership (BTSG)

Source: Nexqual, July 25, 2026 at 03:02 UTC.

Leadership (BTSG)

Brightspring Health Services, Inc. is led by Jon B. Rousseau (age 51), Chairman, President & CEO, per Nexqual as of July 25, 2026 at 03:02 UTC.

Major Backers & Investors (BTSG)

Notable institutional backers of Brightspring Health Services, Inc. include Kohlberg Kravis Roberts & Co. L.P., FMR, LLC, T. Rowe Price, according to Nexqual as of July 25, 2026 at 03:02 UTC.

Active Investors

Index Funds (Passive)

Source: Nexqual, July 25, 2026 at 03:02 UTC.

From Brightspring Health Services, Inc.'s Latest SEC 10-K Filing (filed 2026-02-27)

Key Strengths & Strategy (as disclosed to the SEC)

• In 2020, we also completed the implementation of a financial systems transformation, including the implementation of Oracle Fusion and a new budgeting and forecasting system.
• We believe that we are positioned to identify potential medical problems and avoid adverse events due to our highly proximate position to patients. • Market-leading scale with a focus on operational excellence and coordinated front-line care – We manage one of the nation's largest independent platforms of both pharmacy and provider services offered on a daily basis in home and community settings – to address the multiple needs of medically complex Senior and Specialty patients.
• Over $40 billion in annual U.S. health care spending is attributed to hospital readmissions, and home health care can reduce 365-day post-discharge costs by more than $6,000 per patient, each per the American Journal of Medicine.
• Scale from our pharmacy and provider businesses allow us to effectively deliver and coordinate integrated solutions to and across patient types and care settings, which we believe will be more important in the ongoing development of value-based care solutions.

Partnerships

• On January 17, 2025, we entered into a purchase agreement with National Mentor Holding, Inc. to divest the Company's community living services, home and community based waiver programs, and intermediate care facilities (the "Community Living business"), for $835 million, subject to typical adjustments for working capital and other customary items.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:02 UTC. This page is informational and not investment advice.